Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents.

Rosario IemmoloValentina La CognataGiovanna MorelloMaria GuarnacciaMariamena ArbitrioEnrico AlessiSebastiano Cavallaro

Published in: Biosensors (2020)

The high performance in terms of sensibility and specificity of this lab-on-chip supports its further translation to clinical diagnostics, where it may effectively promote precision medicine.

Keyphrases

high throughput
adverse drug
circulating tumor cells
single cell
electronic health record
emergency department
genome wide
drug induced